HU227742B1
(en)
|
1996-10-18 |
2012-02-28 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
US7601709B2
(en)
|
2003-02-07 |
2009-10-13 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic hepatitis C serine protease inhibitors
|
US7176208B2
(en)
|
2003-04-18 |
2007-02-13 |
Enanta Pharmaceuticals, Inc. |
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
|
WO2004113365A2
(fr)
*
|
2003-06-05 |
2004-12-29 |
Enanta Pharmaceuticals, Inc. |
Inhibiteurs de la tripeptide hepatite c serine protease
|
US7273851B2
(en)
|
2003-06-05 |
2007-09-25 |
Enanta Pharmaceuticals, Inc. |
Tri-peptide hepatitis C serine protease inhibitors
|
US7125845B2
(en)
|
2003-07-03 |
2006-10-24 |
Enanta Pharmaceuticals, Inc. |
Aza-peptide macrocyclic hepatitis C serine protease inhibitors
|
ATE497505T1
(de)
*
|
2003-09-26 |
2011-02-15 |
Schering Corp |
Makrocyclische inhibitoren der ns3-serinprotease des hepatitis-c-virus
|
WO2005037860A2
(fr)
|
2003-10-10 |
2005-04-28 |
Vertex Pharmaceuticals Incoporated |
Inhibiteurs de serine proteases, en particulier la ns3-ns4a protease du hcv
|
ES2336009T3
(es)
|
2004-01-30 |
2010-04-07 |
Medivir Ab |
Inhibidores de la ns-3 serina proteasa del vhc.
|
EP2311851A3
(fr)
*
|
2004-02-04 |
2011-05-25 |
Vertex Pharmaceuticals Incorporated |
Inhibitoren der Serinproteasen, insbesondere der HCV-NS3-NS4A-Protease
|
EA013207B1
(ru)
|
2004-02-20 |
2010-04-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Ингибиторы вирусной полимеразы
|
EP1828224B1
(fr)
*
|
2004-12-22 |
2016-04-06 |
Ambrx, Inc. |
Compositions contenant des acides amines non naturels et des polypeptides, procedes impliquant ces acides amines non naturels et polypeptides, et utilisations desdits acides amines non naturels et polypeptides
|
US7323447B2
(en)
|
2005-02-08 |
2008-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
RU2456296C2
(ru)
*
|
2005-03-08 |
2012-07-20 |
Берингер Ингельхайм Интернациональ Гмбх |
Способ получения макроциклических соединений
|
US7592336B2
(en)
|
2005-05-10 |
2009-09-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7601686B2
(en)
|
2005-07-11 |
2009-10-13 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
TWI387603B
(zh)
*
|
2005-07-20 |
2013-03-01 |
Merck Sharp & Dohme |
Hcv ns3蛋白酶抑制劑
|
WO2007015824A2
(fr)
|
2005-07-25 |
2007-02-08 |
Intermune, Inc. |
Nouveaux inhibiteurs macrocycliques de la multiplication du virus de l’hépatite c
|
TWI383980B
(zh)
|
2005-07-29 |
2013-02-01 |
Tibotec Pharm Ltd |
C型肝炎病毒之大環抑制劑
|
KR101381387B1
(ko)
|
2005-07-29 |
2014-04-11 |
메디비르 아베 |
C형 간염 바이러스의 마크로사이클릭 억제제
|
TWI382025B
(zh)
|
2005-07-29 |
2013-01-11 |
Tibotec Pharm Ltd |
C型肝炎病毒之大環抑制劑(四)
|
PE20070211A1
(es)
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
BRPI0614638A2
(pt)
|
2005-07-29 |
2011-04-12 |
Tibotec Pharm Ltd |
compostos inibidores macrocìclicos do vìrus da hepatite c, uso dos mesmos, processo para a preparação dos mesmos, combinação e composição farmacêutica
|
PE20070343A1
(es)
*
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Inhibidores macrociclicos del virus de la hepatitis c
|
CN101273052B
(zh)
*
|
2005-07-29 |
2016-01-13 |
爱尔兰詹森科学公司 |
丙型肝炎病毒的大环抑制剂
|
RS52058B
(en)
|
2005-07-29 |
2012-04-30 |
Tibotec Pharmaceuticals |
MACROCYCLIC HEPATITIS VIRUS INHIBITORS C
|
AU2006275413B2
(en)
|
2005-08-02 |
2012-07-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
JP5015154B2
(ja)
|
2005-08-12 |
2012-08-29 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ウイルスポリメラーゼインヒビター
|
CN101291909B
(zh)
|
2005-08-19 |
2012-09-05 |
弗特克斯药品有限公司 |
方法和中间体
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
WO2007044893A2
(fr)
|
2005-10-11 |
2007-04-19 |
Intermune, Inc. |
Composés et méthodes pour l'inhibition de la réplication du virus de l'hépatite c
|
US7772183B2
(en)
|
2005-10-12 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7741281B2
(en)
|
2005-11-03 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
KR20140098867A
(ko)
|
2005-11-11 |
2014-08-08 |
버텍스 파마슈티칼스 인코포레이티드 |
C형 간염 바이러스 변이체
|
US7705138B2
(en)
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
US7816348B2
(en)
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US8268776B2
(en)
|
2006-06-06 |
2012-09-18 |
Enanta Pharmaceuticals, Inc. |
Macrocylic oximyl hepatitis C protease inhibitors
|
US20070281884A1
(en)
*
|
2006-06-06 |
2007-12-06 |
Ying Sun |
Macrocyclic oximyl hepatitis C protease inhibitors
|
US9526769B2
(en)
|
2006-06-06 |
2016-12-27 |
Enanta Pharmaceuticals, Inc. |
Macrocylic oximyl hepatitis C protease inhibitors
|
TWI454264B
(zh)
*
|
2006-06-26 |
2014-10-01 |
Enanta Pharm Inc |
喹啉基巨環c型肝炎病毒絲胺酸蛋白酶抑制劑
|
RU2008152171A
(ru)
|
2006-07-05 |
2010-08-10 |
Интермьюн, Инк. (Us) |
Новые ингибиторы вирусной репликации гепатита с
|
US7754720B2
(en)
|
2006-07-07 |
2010-07-13 |
Gilead Sciences, Inc. |
Pyridazine compound and use thereof
|
UA96296C2
(en)
*
|
2006-07-07 |
2011-10-25 |
Гилиад Сайенсиз, Инк. |
Pyridazine compounds and use thereof
|
US7935670B2
(en)
|
2006-07-11 |
2011-05-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
JP5517614B2
(ja)
|
2006-07-13 |
2014-06-11 |
アキリオン ファーマシューティカルズ,インコーポレーテッド |
ウイルス複製阻害剤としての4−アミノ−4−オキソブタノイルペプチド類
|
WO2008019303A2
(fr)
*
|
2006-08-04 |
2008-02-14 |
Enanta Pharmaceuticals, Inc. |
Inhibiteurs de sérine protéases de l'hépatite c macrocycliques de type pyridazinonyle
|
US7718612B2
(en)
*
|
2007-08-02 |
2010-05-18 |
Enanta Pharmaceuticals, Inc. |
Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
|
AU2007284027A1
(en)
|
2006-08-17 |
2008-02-21 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US8343477B2
(en)
|
2006-11-01 |
2013-01-01 |
Bristol-Myers Squibb Company |
Inhibitors of hepatitis C virus
|
US7772180B2
(en)
|
2006-11-09 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7763584B2
(en)
|
2006-11-16 |
2010-07-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7888464B2
(en)
|
2006-11-16 |
2011-02-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8003604B2
(en)
*
|
2006-11-16 |
2011-08-23 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CA2679563A1
(fr)
*
|
2007-01-08 |
2008-07-17 |
Phenomix Corporation |
Inhibiteurs macrocycliques de la protease du virus de l'hepatite c
|
US8143402B2
(en)
*
|
2007-02-01 |
2012-03-27 |
Tibotec Pharmaceuticals Ltd. |
Polymorphic forms of a macrocyclic inhibitor of HCV
|
WO2008106130A2
(fr)
|
2007-02-26 |
2008-09-04 |
Achillion Pharmaceuticals, Inc. |
Peptides substitués par une amine tertiaire utiles comme inhibiteurs de la réplication du virus de l'hépatite c
|
AU2008248116A1
(en)
|
2007-05-04 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Combination therapy for the treatment of HCV infection
|
AP2874A
(en)
|
2007-06-29 |
2014-03-31 |
Gilead Sciences Inc |
Antiviral compounds
|
KR20100038417A
(ko)
|
2007-06-29 |
2010-04-14 |
길리애드 사이언시즈, 인코포레이티드 |
항바이러스 화합물
|
CA2693997C
(fr)
|
2007-08-03 |
2013-01-15 |
Pierre L. Beaulieu |
Inhibiteurs de polymerase virale
|
US8383583B2
(en)
|
2007-10-26 |
2013-02-26 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors
|
WO2009070692A1
(fr)
|
2007-11-29 |
2009-06-04 |
Enanta Pharmaceuticals, Inc. |
Inhibiteurs de sérine protéase de l'hépatite c macrocycliques, dérivés de la proline, substitués en c5
|
US8030307B2
(en)
|
2007-11-29 |
2011-10-04 |
Enanta Pharmaceuticals, Inc. |
Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease
|
CN101977621A
(zh)
|
2007-12-05 |
2011-02-16 |
益安药业 |
氟化三肽hcv丝氨酸蛋白酶抑制剂
|
US8476257B2
(en)
|
2007-12-19 |
2013-07-02 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US8202996B2
(en)
|
2007-12-21 |
2012-06-19 |
Bristol-Myers Squibb Company |
Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
|
NZ587133A
(en)
*
|
2008-02-04 |
2012-10-26 |
Idenix Pharmaceuticals Inc |
Macrocyclic serine protease inhibitor compounds for treating an HCV infection
|
US8163921B2
(en)
|
2008-04-16 |
2012-04-24 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7964560B2
(en)
|
2008-05-29 |
2011-06-21 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
EP2300491B1
(fr)
|
2008-05-29 |
2016-01-06 |
Bristol-Myers Squibb Company |
Inhibiteurs du virus de l hépatite c
|
US8207341B2
(en)
|
2008-09-04 |
2012-06-26 |
Bristol-Myers Squibb Company |
Process or synthesizing substituted isoquinolines
|
UY32099A
(es)
*
|
2008-09-11 |
2010-04-30 |
Enanta Pharm Inc |
Inhibidores macrocíclicos de serina proteasas de hepatitis c
|
US8563505B2
(en)
|
2008-09-29 |
2013-10-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8044087B2
(en)
|
2008-09-29 |
2011-10-25 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
ES2527166T3
(es)
|
2008-12-10 |
2015-01-21 |
Achillion Pharmaceuticals, Inc. |
Nuevos péptidos de 4-amino-4-oxobutanoílo como inhibidores de la replicación viral
|
BRPI0922913A2
(pt)
*
|
2008-12-10 |
2015-08-18 |
Achillion Pharmaceuticals Inc |
Análogos cíclicos de peptídeo 4-amino-4-oxobutanoil inibidores de replicação viral
|
US8283310B2
(en)
|
2008-12-15 |
2012-10-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
MX2011007195A
(es)
|
2009-01-07 |
2013-07-12 |
Scynexis Inc |
Derivado de ciclosporina para el uso en el tratamiento de infección de virus de hepatitis c (vhc) y virus de inmunodeficiencia humana (vih).
|
CA2758072A1
(fr)
|
2009-04-08 |
2010-10-14 |
Idenix Pharmaceuticals, Inc. |
Inhibiteurs macrocycliques de la serine protease
|
CA2761650C
(fr)
|
2009-05-13 |
2015-05-26 |
Enanta Pharmaceuticals, Inc. |
Composes macrocycliques comme inhibiteurs du virus de l'hepatite c
|
WO2011017389A1
(fr)
|
2009-08-05 |
2011-02-10 |
Idenix Pharmaceuticals, Inc. |
Inhibiteurs macrocycliques de la sérine protéase macrocyclique utiles contre les infections virales, en particulier le virus de lhépatite c
|
HUE030402T2
(en)
|
2009-09-15 |
2017-05-29 |
Taigen Biotechnology Co Ltd |
HCV protease inhibitors
|
CN103025736B
(zh)
*
|
2010-06-07 |
2016-07-06 |
Abbvie公司 |
大环的丙型肝炎丝氨酸蛋白酶抑制剂
|
CA2812261C
(fr)
|
2010-09-21 |
2017-02-21 |
Enanta Pharmaceuticals, Inc. |
Inhibiteurs de la serine protease du vhc derivee de la proline macrocyclique
|
US8937041B2
(en)
|
2010-12-30 |
2015-01-20 |
Abbvie, Inc. |
Macrocyclic hepatitis C serine protease inhibitors
|
EP2658858A4
(fr)
|
2010-12-30 |
2014-06-25 |
Enanta Pharm Inc |
Inhibiteurs macrocycliques de phénanthridine de sérine protéase d'hépatite c
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
US8957203B2
(en)
|
2011-05-05 |
2015-02-17 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
US8691757B2
(en)
|
2011-06-15 |
2014-04-08 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
SI2909205T1
(sl)
*
|
2012-10-19 |
2017-02-28 |
Bristol-Myers Squibb Company |
9-metil substituiran heksadekahidrociklopropa(e)pirolo(1,2-A)(1,4)diazaciklopentadecinil karbamat derivati kot nestrukturalni 3 (NS3) proteazni inhibitorji za zdravljenje hepatitis C virusnih infekcij
|
US9643999B2
(en)
|
2012-11-02 |
2017-05-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2014070964A1
(fr)
|
2012-11-02 |
2014-05-08 |
Bristol-Myers Squibb Company |
Inhibiteurs du virus de l'hépatite c
|
WO2014071007A1
(fr)
|
2012-11-02 |
2014-05-08 |
Bristol-Myers Squibb Company |
Inhibiteurs du virus de l'hépatite c
|
EP2914614B1
(fr)
|
2012-11-05 |
2017-08-16 |
Bristol-Myers Squibb Company |
Inhibiteurs du virus de l'hépatite c
|
WO2014137869A1
(fr)
|
2013-03-07 |
2014-09-12 |
Bristol-Myers Squibb Company |
Inhibiteurs du virus de l'hépatite c
|
EP2970195B1
(fr)
|
2013-03-14 |
2017-08-02 |
Achillion Pharmaceuticals, Inc. |
Processus de production de sovaprevir
|
WO2014145507A1
(fr)
|
2013-03-15 |
2014-09-18 |
Achillion Pharmaceuticals, Inc. |
Procédé de fabrication d'un analogue cyclique de peptide de 4-amino-4-oxobutanoyle, inhibiteur de réplication virale et leurs intermédiaires
|
US9085607B2
(en)
|
2013-03-15 |
2015-07-21 |
Achillion Pharmaceuticals, Inc. |
ACH-0142684 sodium salt polymorph, composition including the same, and method of manufacture thereof
|
KR20160005686A
(ko)
|
2013-03-15 |
2016-01-15 |
아칠리온 파르마세우티칼스 인코포레이티드 |
소바프레비르 다형체들 및 이의 제조 방법
|
EP3089757A1
(fr)
|
2014-01-03 |
2016-11-09 |
AbbVie Inc. |
Formes galéniques antivirales solides
|
EP2899207A1
(fr)
|
2014-01-28 |
2015-07-29 |
Amikana.Biologics |
Nouveau procédé pour tester l'inhibition de la protéase du HCV
|
CN105130916B
(zh)
*
|
2015-09-30 |
2019-03-01 |
江西师范大学 |
一种高效制备nh-1,2,3***化合物的方法
|
TWI832917B
(zh)
|
2018-11-06 |
2024-02-21 |
美商富曼西公司 |
經取代之甲苯基殺真菌劑
|
WO2021127273A1
(fr)
*
|
2019-12-20 |
2021-06-24 |
Gb004, Inc. |
Dérivés de 1-((6-oxo-1,6-dihydropyridazin-4-yl)méthyl)pipérazine et de 1-((6-oxo-1,6-dihydropyrimidin-4-yl)méthyl)pipérazine utilisés en tant que modulateurs de la prolyl hydroxylase, de l'hif-1 alpha et de la pgk dans le traitement de maladies inflammatoires, du cancer ou d'infections
|
UY39189A
(es)
|
2020-05-06 |
2021-12-31 |
Fmc Corp |
Fungicidas de tolilo sustituido y sus mezclas
|